Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (221-230 of 321) with videos related to

Pageof 33
Sort By:
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
Neuro-Oncology Practice|October 5, 2020
Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregiversDeborah A Forst, Kit Quain, Sophia L Landay, et al.
Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Radiology. Artificial Intelligence|January 10, 2024
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor SegmentationKatharina V Hoebel, Christopher P Bridge, Sara Ahmed, et al.
Scientific Reports|November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports|June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Neuro-Oncology|April 12, 2008
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adultsSantosh Kesari, David Schiff, John W Henson, et al.
Pageof 33

Showing results (221-230 of 321) with videos related to

Sort By:
Pageof 33
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
Neuro-Oncology Practice|October 5, 2020
Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregiversDeborah A Forst, Kit Quain, Sophia L Landay, et al.
Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Radiology. Artificial Intelligence|January 10, 2024
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor SegmentationKatharina V Hoebel, Christopher P Bridge, Sara Ahmed, et al.
Scientific Reports|November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports|June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Neuro-Oncology|April 12, 2008
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adultsSantosh Kesari, David Schiff, John W Henson, et al.
Pageof 33